Article
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a…
medRxiv · 2024 · Arcuschin, C. D.; Kahrizi, K.; Sayaman, R. W.; DiBenedetto, C.; Shen, Y.; Salaberry, P. J.; Zakroui, O.; Schwarzer, C.; Scapozza, A.; Betancur, P.; Saba, J. D.; Coppe, J.-P.; Barcellos-Hoff, M. H.; Kappes, D.; van 't Veer, L.; Schor, I. E.; Munoz, D. P.
Key facts
| Title | Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype |
|---|---|
| First author | Arcuschin, C. D.; Kahrizi, K.; Sayaman, R. W.; DiBenedetto, C.; Shen, Y.; Salaberry, P. J.; Zakroui, O.; Schwarzer, C.; Scapozza, A.; Betancur, P.; Saba, J. D.; Coppe, J.-P.; Barcellos-Hoff, M. H.; Kappes, D.; van 't Veer, L.; Schor, I. E.; Munoz, D. P. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.09.21.614267 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, KIT, MVU, NDS, NJT, OOI, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1